- Home
- ZYXI vs RCAT Comparison
ZYXI vs RCAT Comparison
Compare ZYXI & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- RCAT
- Stock Information
- Founded
- ZYXI 1996
- RCAT 2002
- Country
- ZYXI United States
- RCAT United States
- Employees
- ZYXI N/A
- RCAT N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RCAT Wholesale Distributors
- Sector
- ZYXI Health Care
- RCAT Industrials
- Exchange
- ZYXI Nasdaq
- RCAT Nasdaq
- Market Cap
- ZYXI 72.3M
- RCAT N/A
- IPO Year
- ZYXI N/A
- RCAT 2017
- Fundamental
- Price
- ZYXI $2.62
- RCAT $7.36
- Analyst Decision
- ZYXI Buy
- RCAT Buy
- Analyst Count
- ZYXI 3
- RCAT 1
- Target Price
- ZYXI $6.00
- RCAT $13.00
- AVG Volume (30 Days)
- ZYXI 291.0K
- RCAT 11.8M
- Earning Date
- ZYXI 07-24-2025
- RCAT 08-07-2025
- Dividend Yield
- ZYXI N/A
- RCAT N/A
- EPS Growth
- ZYXI N/A
- RCAT N/A
- EPS
- ZYXI N/A
- RCAT N/A
- Revenue
- ZYXI $172,401,000.00
- RCAT $2,291,089.00
- Revenue This Year
- ZYXI N/A
- RCAT $1,023.35
- Revenue Next Year
- ZYXI $19.55
- RCAT $88.95
- P/E Ratio
- ZYXI N/A
- RCAT N/A
- Revenue Growth
- ZYXI N/A
- RCAT N/A
- 52 Week Low
- ZYXI $1.66
- RCAT $1.10
- 52 Week High
- ZYXI $10.62
- RCAT $15.27
- Technical
- Relative Strength Index (RSI)
- ZYXI 61.26
- RCAT 51.38
- Support Level
- ZYXI $2.30
- RCAT $6.98
- Resistance Level
- ZYXI $2.58
- RCAT $7.60
- Average True Range (ATR)
- ZYXI 0.16
- RCAT 0.73
- MACD
- ZYXI 0.05
- RCAT -0.14
- Stochastic Oscillator
- ZYXI 96.98
- RCAT 27.13
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.